Clinical Trial CTSUGI80702-M


A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or placebo for patients with Resected Stage III Colon Cancer

Principal Investigator(s)

John Murray


  • Protocol No. CTSUGI80702-M
  • Open Date: 05/05/2011
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites:
  • Therapies: Chemotherapy - cytotoxic
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College
  • Secondary Protocol No: 80702



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.